Načítá se...
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disorder with complex biology and significant clinical heterogeneity. Many preclinical and early phase ALS clinical trials have yielded promising results that could not be replicated in larger phase 3 confirmatory trials. One re...
Uloženo v:
| Vydáno v: | Muscle Nerve |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7496557/ https://ncbi.nlm.nih.gov/pubmed/31899540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.26801 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|